ONC.TO
Oncolytics Biotech Inc
Price:  
1.25 
CAD
Volume:  
28,390.00
Canada | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ONC.TO WACC - Weighted Average Cost of Capital

The WACC of Oncolytics Biotech Inc (ONC.TO) is 8.5%.

The Cost of Equity of Oncolytics Biotech Inc (ONC.TO) is 8.50%.
The Cost of Debt of Oncolytics Biotech Inc (ONC.TO) is 5.00%.

Range Selected
Cost of equity 6.60% - 10.40% 8.50%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.6% - 10.4% 8.5%
WACC

ONC.TO WACC calculation

Category Low High
Long-term bond rate 3.2% 3.7%
Equity market risk premium 5.1% 6.1%
Adjusted beta 0.67 1.03
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.60% 10.40%
Tax rate 0.10% 0.20%
Debt/Equity ratio 0 0
Cost of debt 5.00% 5.00%
After-tax WACC 6.6% 10.4%
Selected WACC 8.5%